Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name prescription medicine

CPDA-1

Generic name: Anticoagulant citrate phosphate dextrose adenine

Company: Fenwal, Inc.

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is CPDA-1?
CPDA-1 is a brand name of Anticoagulant citrate phosphate dextrose adenine, a prescription medicine. The FDA NDC Directory lists 11 CPDA-1 products in 2 strengths and forms.
Who makes CPDA-1?
Fenwal, Inc. lists 11 of the 11 CPDA-1 products in the FDA NDC Directory.
Is there a generic or store brand of CPDA-1?
Other products of Anticoagulant citrate phosphate dextrose adenine are listed with the FDA, but none in exactly the same strength and form as a CPDA-1 product.
Has CPDA-1 been recalled?
No recall linked to CPDA-1 products (by their NDC code or label) appears in the FDA enforcement reports we use.

What CPDA-1 is

Each CPDA-1 product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Anticoagulant citrate phosphate dextrose adenine · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
adenine 17.3 mg/63 mL · anhydrous citric acid 188 mg/63 mL · dextrose monohydrate 2 g/63 mL · sodium phosphate, monobasic, monohydrate 140 mg/63 mL · trisodium citrate dihydrate 1.66 g/63 mL
solution (intravenous)
CPDA-1 None listed DailyMed
adenine 19.3 mg/70 mL · anhydrous citric acid 209 mg/70 mL · dextrose monohydrate 2.23 g/70 mL · sodium phosphate, monobasic, monohydrate 155 mg/70 mL · trisodium citrate dihydrate 1.84 g/70 mL
solution (intravenous)
CPDA-1 None listed DailyMed

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Anticoagulant citrate phosphate dextrose adenine →

FDA approval

No Drugs@FDA application is linked to these products.

Companies that list CPDA-1

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of CPDA-1 products.

Recalls

No recall linked to CPDA-1 products (by their NDC code or label) appears in the FDA enforcement reports.

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers